Ken Griffin Utah Medical Products Inc Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Utah Medical Products Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 9,367 shares of UTMD stock, worth $539,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,367

Previous 25,895 63.83%

Holding current value

$539,351

Previous $1.45 Million 63.27%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$51.75 - $57.36 $855,324 - $948,046	-16,528 Reduced 63.83%	9,367 $533,000
Q1 2025 May 15, 2025	BUY	$56.04 - $64.17 $890,587 - $1.02 Million	15,892 Added 158.87%	25,895 $1.45 Million
Q4 2024 Feb 14, 2025	SELL	$60.9 - $68.52 $421,306 - $474,021	-6,918 Reduced 40.88%	10,003 $614,000
Q3 2024 Nov 14, 2024	SELL	$65.79 - $75.08 $253,225 - $288,982	-3,849 Reduced 18.53%	16,921 $1.13 Million
Q2 2024 Aug 14, 2024	SELL	$65.92 - $70.99 $1.22 Million - $1.31 Million	-18,448 Reduced 47.04%	20,770 $1.39 Million
Q1 2024 May 15, 2024	BUY	$68.14 - $84.23 $2.19 Million - $2.7 Million	32,087 Added 449.96%	39,218 $2.79 Million
Q4 2023 Feb 14, 2024	BUY	$77.07 - $87.05 $194,370 - $219,540	2,522 Added 54.72%	7,131 $600,000
Q3 2023 Nov 14, 2023	SELL	$83.86 - $99.16 $375,021 - $443,443	-4,472 Reduced 49.25%	4,609 $396,000
Q2 2023 Aug 14, 2023	SELL	$87.76 - $99.95 $28,346 - $32,283	-323 Reduced 3.43%	9,081 $846,000
Q1 2023 May 15, 2023	BUY	$87.14 - $100.3 $523,537 - $602,602	6,008 Added 176.91%	9,404 $891,000
Q4 2022 Feb 14, 2023	BUY	$82.45 - $101.88 $72,803 - $89,960	883 Added 35.14%	3,396 $341,000
Q3 2022 Nov 14, 2022	BUY	$80.73 - $95.26 $202,874 - $239,388	2,513 New	2,513 $214,000
Q2 2022 Aug 15, 2022	SELL	$81.49 - $90.28 $362,711 - $401,836	-4,451 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$86.04 - $99.89 $183,093 - $212,565	2,128 Added 91.61%	4,451 $400,000
Q4 2021 Feb 14, 2022	BUY	$88.84 - $124.71 $206,375 - $289,701	2,323 New	2,323 $0
Q4 2020 Feb 16, 2021	SELL	$79.35 - $94.4 $224,798 - $267,435	-2,833 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$78.22 - $92.62 $33,791 - $40,011	-432 Reduced 13.23%	2,833 $227,000
Q2 2020 Aug 14, 2020	SELL	$78.0 - $106.28 $107,874 - $146,985	-1,383 Reduced 29.75%	3,265 $290,000
Q1 2020 May 15, 2020	BUY	$77.05 - $108.52 $194,936 - $274,555	2,530 Added 119.45%	4,648 $437,000
Q4 2019 Feb 14, 2020	SELL	$91.85 - $109.3 $53,824 - $64,049	-586 Reduced 21.67%	2,118 $229,000
Q3 2019 Nov 14, 2019	BUY	$83.55 - $100.0 $24,480 - $29,300	293 Added 12.15%	2,704 $0
Q3 2018 Nov 13, 2018	BUY	$86.0 - $114.75 $207,346 - $276,662	2,411 New	2,411 $0

Others Institutions Holding UTMD

# of Institutions

109

Shares Held

2.2M

Call Options Held

Put Options Held

View Full List

About UTAH MEDICAL PRODUCTS INC

Ticker UTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 3,625,200
Market Cap $209M
Description
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...

More about UTMD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account